Metabolic diseases and pro- and prebiotics: Mechanistic insights

<p>Abstract</p> <p>Metabolic diseases, such as obesity and type 2 diabetes, are world-wide health problems. The prevalence of metabolic diseases is associated with dynamic changes in dietary macronutrient intake during the past decades. Based on national statistics and from a publi...

Full description

Bibliographic Details
Main Authors: Nakamura Yukiko K, Omaye Stanley T
Format: Article
Language:English
Published: BMC 2012-06-01
Series:Nutrition & Metabolism
Subjects:
Online Access:http://www.nutritionandmetabolism.com/content/9/1/60
_version_ 1818513642884169728
author Nakamura Yukiko K
Omaye Stanley T
author_facet Nakamura Yukiko K
Omaye Stanley T
author_sort Nakamura Yukiko K
collection DOAJ
description <p>Abstract</p> <p>Metabolic diseases, such as obesity and type 2 diabetes, are world-wide health problems. The prevalence of metabolic diseases is associated with dynamic changes in dietary macronutrient intake during the past decades. Based on national statistics and from a public health viewpoint, traditional approaches, such as diet and physical activity, have been unsuccessful in decreasing the prevalence of metabolic diseases. Since the approaches strongly rely on individual’s behavior and motivation, novel science-based strategies should be considered for prevention and therapy for the diseases. Metabolism and immune system are linked. Both overnutrition and infection result in inflammation through nutrient and pathogen sensing systems which recognize compounds with structural similarities. Dietary macronutrients (fats and sugars) can induce inflammation through activation of an innate immune receptor, Toll-like receptor 4 (TLR4). Long-term intake of diets high in fats and meats appear to induce chronic systemic low-grade inflammation, endotoxicity, and metabolic diseases. Recent investigations support the idea of the involvement of intestinal bacteria in host metabolism and preventative and therapeutic potentials of probiotic and prebiotic interventions for metabolic diseases. Specific intestinal bacteria seem to serve as lipopolysaccharide (LPS) sources through LPS and/or bacterial translocation into the circulation due to a vulnerable microbial barrier and increased intestinal permeability and to play a role in systemic inflammation and progression of metabolic diseases. This review focuses on mechanistic links between metabolic diseases (mainly obesity and type 2 diabetes), chronic systemic low-grade inflammation, intestinal environment, and nutrition and prospective views of probiotic and prebiotic interventions for the diseases.</p>
first_indexed 2024-12-11T00:04:19Z
format Article
id doaj.art-b800891ae3eb439b85478d90f25f25f6
institution Directory Open Access Journal
issn 1743-7075
language English
last_indexed 2024-12-11T00:04:19Z
publishDate 2012-06-01
publisher BMC
record_format Article
series Nutrition & Metabolism
spelling doaj.art-b800891ae3eb439b85478d90f25f25f62022-12-22T01:28:22ZengBMCNutrition & Metabolism1743-70752012-06-01916010.1186/1743-7075-9-60Metabolic diseases and pro- and prebiotics: Mechanistic insightsNakamura Yukiko KOmaye Stanley T<p>Abstract</p> <p>Metabolic diseases, such as obesity and type 2 diabetes, are world-wide health problems. The prevalence of metabolic diseases is associated with dynamic changes in dietary macronutrient intake during the past decades. Based on national statistics and from a public health viewpoint, traditional approaches, such as diet and physical activity, have been unsuccessful in decreasing the prevalence of metabolic diseases. Since the approaches strongly rely on individual’s behavior and motivation, novel science-based strategies should be considered for prevention and therapy for the diseases. Metabolism and immune system are linked. Both overnutrition and infection result in inflammation through nutrient and pathogen sensing systems which recognize compounds with structural similarities. Dietary macronutrients (fats and sugars) can induce inflammation through activation of an innate immune receptor, Toll-like receptor 4 (TLR4). Long-term intake of diets high in fats and meats appear to induce chronic systemic low-grade inflammation, endotoxicity, and metabolic diseases. Recent investigations support the idea of the involvement of intestinal bacteria in host metabolism and preventative and therapeutic potentials of probiotic and prebiotic interventions for metabolic diseases. Specific intestinal bacteria seem to serve as lipopolysaccharide (LPS) sources through LPS and/or bacterial translocation into the circulation due to a vulnerable microbial barrier and increased intestinal permeability and to play a role in systemic inflammation and progression of metabolic diseases. This review focuses on mechanistic links between metabolic diseases (mainly obesity and type 2 diabetes), chronic systemic low-grade inflammation, intestinal environment, and nutrition and prospective views of probiotic and prebiotic interventions for the diseases.</p>http://www.nutritionandmetabolism.com/content/9/1/60ObesityType 2 diabetesInflammationLipopolysaccharidesIntestinal bacteriaProbioticsPrebiotics
spellingShingle Nakamura Yukiko K
Omaye Stanley T
Metabolic diseases and pro- and prebiotics: Mechanistic insights
Nutrition & Metabolism
Obesity
Type 2 diabetes
Inflammation
Lipopolysaccharides
Intestinal bacteria
Probiotics
Prebiotics
title Metabolic diseases and pro- and prebiotics: Mechanistic insights
title_full Metabolic diseases and pro- and prebiotics: Mechanistic insights
title_fullStr Metabolic diseases and pro- and prebiotics: Mechanistic insights
title_full_unstemmed Metabolic diseases and pro- and prebiotics: Mechanistic insights
title_short Metabolic diseases and pro- and prebiotics: Mechanistic insights
title_sort metabolic diseases and pro and prebiotics mechanistic insights
topic Obesity
Type 2 diabetes
Inflammation
Lipopolysaccharides
Intestinal bacteria
Probiotics
Prebiotics
url http://www.nutritionandmetabolism.com/content/9/1/60
work_keys_str_mv AT nakamurayukikok metabolicdiseasesandproandprebioticsmechanisticinsights
AT omayestanleyt metabolicdiseasesandproandprebioticsmechanisticinsights